Sam Altman-Backed Retro Biosciences Raises $1B to Extend Human Lifespan
OpenAI’s Sam Altman is backing Retro Biosciences’ ambitious $1B fundraising round to develop longevity drugs targeting diseases like Alzheimer’s. The Billion-Dollar Bet on Longevity: Sam Altman’s Vision for Extending Life … Read More